INVENTIVA (EPA:IVA) Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China
Transparency directive : regulatory news
25/05/2023 22:00
INVENTIVA 's latest news
26/05/2023 22:00
25/05/2023 22:00
25/05/2023 15:50
16/05/2023 22:00
04/05/2023 08:31
30/03/2023 14:19
29/03/2023 22:00
23/03/2023 22:00
14/02/2023 23:00
14/02/2023 22:00
Other stories
04/06/2023 15:18
04/06/2023 09:43
04/06/2023 16:42
04/06/2023 09:29
04/06/2023 15:11
04/06/2023 15:32
04/06/2023 15:34
04/06/2023 12:14
04/06/2023 11:27
04/06/2023 10:31
04/06/2023 16:08
04/06/2023 16:36
04/06/2023 09:11
04/06/2023 14:41
04/06/2023 12:31
04/06/2023 14:53
04/06/2023 08:41
03/06/2023 01:01
04/06/2023 15:27
04/06/2023 13:00
03/06/2023 08:33
03/06/2023 15:57
04/06/2023 11:26
04/06/2023 09:16
04/06/2023 13:13
04/06/2023 14:10
04/06/2023 16:32
04/06/2023 14:52
04/06/2023 15:07
04/06/2023 11:45
04/06/2023 13:15
03/06/2023 10:01
02/06/2023 17:23
03/06/2023 14:53
04/06/2023 16:22
04/06/2023 11:00
04/06/2023 14:00
03/06/2023 23:17